Epigenome-based cancer risk prediction: rationale, opportunities and challenges
Windschwendter M, et al. (including Joly Y) "Epigenome-based cancer risk prediction: rationale, opportunities and challenges" 1:15 (2018) Nature Reviews Clinical Oncology, 292-309.
Ce contenu a été mis à jour le 29 mai 2018 à 10 h 14 min.